MYC overexpression, caused by gene rearrangements and mutations, has been observed in various hematological malignancies, especially in invasive B-cell lymphomas, such as DLBCLs and BLs [122,123,124]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.